Sharon Avkin Nachum

VP, Technology at EdiTy Therapeutics

Sharon is an experienced biochemist and renowned oligo nucleotides expert. At QBI, she headed the entire planning of pre-clinical studies the pre-clinical siRNA pipeline, including in vitro and in vivo trials.

Links

Timeline

  • VP, Technology

    Current role